Morgan Stanley Avid Bioservices, Inc. Transaction History

Morgan Stanley

$1.39 Trillion
Q4 2024

A detailed history of Morgan Stanley transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Morgan Stanley holds 466,631 shares of CDMO stock, worth $5.83 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

466,631

Previous 712,700 34.53%

Holding current value

$5.83 Million

Previous $8.11 Million 28.95%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$9.96 - $12.36 $2.45 Million - $3.04 Million	-246,069 Reduced 34.53%	466,631 $5.76 Million
Q3 2024 Nov 14, 2024	BUY	$6.7 - $12.45 $794,003 - $1.48 Million	118,508 Added 19.94%	712,700 $8.11 Million
Q2 2024 Oct 17, 2024	SELL	$6.34 - $9.28 $5.03 Million - $7.37 Million	-793,910 Reduced 57.19%	594,192 $4.24 Million
Q2 2024 Aug 14, 2024	SELL	$6.34 - $9.28 $5.03 Million - $7.37 Million	-793,910 Reduced 57.19%	594,192 $4.24 Million
Q1 2024 Oct 17, 2024	BUY	$5.86 - $8.79 $4.65 Million - $6.98 Million	793,910 Added 133.61%	1,388,102 $9.3 Million
Q1 2024 Aug 16, 2024	BUY	$5.86 - $8.79 $1.87 Million - $2.81 Million	319,164 Added 29.86%	1,388,102 $9.3 Million
Q1 2024 May 15, 2024	BUY	$5.86 - $8.79 $1.87 Million - $2.81 Million	319,164 Added 29.86%	1,388,102 $9.3 Million
Q4 2023 Aug 16, 2024	BUY	$4.64 - $9.56 $2.2 Million - $4.54 Million	474,746 Added 79.9%	1,068,938 $6.95 Million
Q4 2023 Feb 13, 2024	BUY	$4.64 - $9.56 $196,921 - $405,726	42,440 Added 4.13%	1,068,938 $6.95 Million
Q3 2023 Nov 15, 2023	SELL	$9.4 - $14.04 $246,383 - $368,002	-26,211 Reduced 2.49%	1,026,498 $9.69 Million
Q2 2023 Aug 14, 2023	SELL	$12.96 - $20.93 $302,628 - $488,736	-23,351 Reduced 2.17%	1,052,709 $14.7 Million
Q1 2023 May 15, 2023	SELL	$13.48 - $18.79 $1.2 Million - $1.67 Million	-89,034 Reduced 7.64%	1,076,060 $20.2 Million
Q4 2022 Feb 14, 2023	BUY	$12.61 - $18.74 $1.89 Million - $2.81 Million	150,101 Added 14.79%	1,165,094 $16 Million
Q3 2022 Nov 14, 2022	SELL	$15.33 - $20.36 $2.63 Million - $3.49 Million	-171,323 Reduced 14.44%	1,014,993 $19.4 Million
Q2 2022 Oct 27, 2022	SELL	$11.63 - $21.55 $539,166 - $999,058	-46,360 Reduced 3.76%	1,186,316 $18.1 Million
Q2 2022 Aug 15, 2022	SELL	$11.63 - $21.55 $539,166 - $999,058	-46,360 Reduced 3.76%	1,186,316 $18.1 Million
Q1 2022 Oct 27, 2022	BUY	$16.63 - $27.73 $770,966 - $1.29 Million	46,360 Added 3.91%	1,232,676 $25.1 Million
Q1 2022 May 13, 2022	BUY	$16.63 - $27.73 $9.48 Million - $15.8 Million	569,759 Added 85.95%	1,232,676 $25.1 Million
Q4 2021 Feb 14, 2022	BUY	$20.7 - $34.18 $3.34 Million - $5.51 Million	161,149 Added 32.12%	662,917 $19.3 Million
Q3 2021 Nov 15, 2021	BUY	$19.05 - $28.32 $9.56 Million - $14.2 Million	501,768 New	501,768 $10.8 Million

Others Institutions Holding CDMO

# of Institutions

209

Shares Held

67.1M

Call Options Held

216K

Put Options Held

4.6K

View Full List

About Avid Bioservices, Inc.

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $776M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

More about CDMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account